Cargando…

Influence of severity of infection on the effect of appropriate antimicrobial therapy for Acinetobacter baumannii bacteremic pneumonia

BACKGROUND: The impact of appropriate antimicrobial therapy for A. baumannii bacteremic pneumonia has not been well established due to the inclusion of the three phenotypically indistinguishable Acinetobacter species and confounding factors including underlying diseases and severity of infection. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Fang-Yu, How, Chorng-Kuang, Wang, Yung-Chih, Cheng, Aristine, Yang, Ya-Sung, Kuo, Shu-Chen, Liu, Chang-Pan, Liu, Yuag-Meng, Chen, Te-Li, Lee, Yi-Tzu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523485/ https://www.ncbi.nlm.nih.gov/pubmed/32993810 http://dx.doi.org/10.1186/s13756-020-00824-4

Ejemplares similares

Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteraemic pneumonia
por: Wang, Yung-Chih, et al.
Publicado: (2018)

Biofilm formation is not an independent risk factor for mortality in patients with Acinetobacter baumannii bacteremia
por: Chiang, Tsung-Ta, et al.
Publicado: (2022)

A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii
por: Chiu, Chun-Hsiang, et al.
Publicado: (2015)

Bacteremic and non-bacteremic pneumonia caused by Acinetobacter baumannii in ICUs of South China: A Clinical and Microbiological Study
por: Tan, Yunfang, et al.
Publicado: (2017)

Whole-Genome Sequencing to Differentiate Relapse From Reinfection in Community-Onset Bacteremic Acinetobacter baumannii Pneumonia
por: Meumann, Ella M, et al.
Publicado: (2019)

Is Polymicrobial Bacteremia an Independent Risk Factor for Mortality in Acinetobacter baumannii Bacteremia?
por: Wang, Yung-Chih, et al.
Publicado: (2020)

Carbapenem Breakpoints for Acinetobacter baumannii Group: Supporting Clinical Outcome Data from Patients with Bacteremia
por: Lee, Yi-Tzu, et al.
Publicado: (2016)

Confronting Tigecycline-Resistant Acinetobacter baumannii via Immunization Against Conserved Resistance Determinants
por: Chiang, Ming-Hsien, et al.
Publicado: (2020)

Identification of potential therapeutic antimicrobial peptides against Acinetobacter baumannii in a mouse model of pneumonia
por: Jung, Chiau-Jing, et al.
Publicado: (2021)

Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?
por: Yang, Ya-Sung, et al.
Publicado: (2013)

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2013)

Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii
por: Kuo, Shu-Chen, et al.
Publicado: (2015)

Bacterial membrane vesicles from Acinetobacter baumannii induced by ceftazidime are more virulent than those induced by imipenem
por: Chiu, Chun-Hsiang, et al.
Publicado: (2020)

Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
por: Jean, Shio-Shin, et al.
Publicado: (2018)

A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?
por: Guillamet, Cristina Vazquez, et al.
Publicado: (2016)

Predictors of mortality among bacteremic patients with septic shock receiving appropriate antimicrobial therapy
por: Leedahl, David D, et al.
Publicado: (2014)

Moraxella catarrhalis bacteremic pneumonia
por: Anezaki, Hiroki, et al.
Publicado: (2020)

Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy
por: Kim, Youn Jeong, et al.
Publicado: (2012)

Transcriptome profiling in imipenem-selected Acinetobacter baumannii
por: Chang, Kai-Chih, et al.
Publicado: (2014)

When appropriate antibiotic therapy is relevant in bacteremic septic patients
por: Bagnulo, H, et al.
Publicado: (2008)

Role of immunodeficiency in Acinetobacter baumannii associated pneumonia in mice
por: Liu, Ai-Ran, et al.
Publicado: (2020)

Epididymitis associated with bacteremic pneumococcal pneumonia
por: Berlinrut, Ilan, et al.
Publicado: (2021)

Bacteremic pneumococcal pneumonia: arrhythmogenic disease
por: Fernandez, Leyre Serrano, et al.
Publicado: (2022)

Computational screening of antimicrobial peptides for Acinetobacter baumannii
por: Majumder, Ayan, et al.
Publicado: (2019)

Clinical Characteristics and Prognosis of Hospital-Acquired Klebsiella pneumoniae Bacteremic Pneumonia versus Escherichia coli Bacteremic Pneumonia: A Retrospective Comparative Study
por: Li, Fuxing, et al.
Publicado: (2023)

Clinical and Microbiological Characteristics of Bacteremic Pneumonia Caused by Klebsiella pneumoniae
por: Chen, I-Ren, et al.
Publicado: (2022)

Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: Clinical and microbiological characteristics in Taiwan, 2001-2008
por: Lin, Yi-Tsung, et al.
Publicado: (2010)

Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2
por: Peng, Shih-Yi, et al.
Publicado: (2017)

Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Taiwan
por: Ilsan, Noor Andryan, et al.
Publicado: (2021)

Pseudomembranous Aspergillus tracheobronchitis with secondary Acinetobacter baumannii pneumonia
por: Mahismita, Patro, et al.
Publicado: (2020)

DksA Modulates Antimicrobial Susceptibility of Acinetobacter baumannii
por: Kim, Nayeong, et al.
Publicado: (2021)

Aging exacerbates mortality of Acinetobacter baumannii pneumonia and reduces the efficacies of antibiotics and vaccine
por: Gu, Hao, et al.
Publicado: (2018)

Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against Acinetobacter baumannii in Patients with Hospital-Acquired Pneumonia
por: Zhou, Yingjie, et al.
Publicado: (2022)

Macrolide Resistance in Adults with Bacteremic Pneumococcal Pneumonia
por: Metlay, Joshua P., et al.
Publicado: (2006)

Community-acquired pneumonia infections by Acinetobacter baumannii: How does alcohol impact the antimicrobial functions of macrophages?
por: Eugenin, Eliseo A
Publicado: (2013)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Mantzana, Paraskevi, et al.
Publicado: (2023)

Dissemination of imipenem-resistant Acinetobacter baumannii with new plasmid-borne bla(OXA-72) in Taiwan
por: Kuo, Shu-Chen, et al.
Publicado: (2013)

Antimicrobial Susceptibilities of Clinical Acinetobacter baumannii Isolates With Different Genotypes
por: Altun, Hatice Uludag, et al.
Publicado: (2014)

Exploring the Antimicrobial Action of Quaternary Amines against Acinetobacter baumannii
por: Knauf, Gregory A., et al.
Publicado: (2018)

The Involvement of the csy1 Gene in the Antimicrobial Resistance of Acinetobacter baumannii
por: Guo, Tingting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d6l8nbij076mr6r5qgm3b23v2h